About
A biopharma-focused venture capital fund formed as a partnership between SBI Holdings (Japan) and Vertex Israel, expanding into new high-tech sectors.
SBI JI Innovation Fund was established in June 2017 as a joint venture between SBI Holdings, a Japanese financial services group, and Vertex Israel, a prominent Israeli venture capital firm. Initially focused on bio-investments, the fund actively seeks to invest in exceptional Israeli or Israel-related venture-backed biopharma and high-tech companies across various development stages. Following the successful investment period of its initial bio fund, SBI JI is broadening its investment scope to include new sectors and geographies, fostering a bridge between Israel and Asia.
Identity
| Name | SBI JI Innovation Fund |
|---|---|
| Slug | sbi-ji-innovation-fund-2 |
| Legal name | SBI JI Innovation Advisory Ltd. |
| Type / kind | corporate_vc |
Status
| Status | active |
|---|---|
| Last update | 2026-05-07 |
Location
| HQ country | Israel |
|---|---|
| HQ country code | IL |
| HQ city | Tel Aviv-Yafo |
Web & social
| Website | https://sbi-ji.co.il |
|---|
Classifications
Tags
venture-capitalcorporate-vcbiopharmahealthcarehigh-techfintechcyber-securitybiotechnologyimmunologyimmunotherapyoncologypharmaceuticalsgenetic-disorderschronic-diseasealzheimers
Funding
| Total raised | — |
|---|
Raw source document
Show full JSON (0 KB)
{}